GSK PLC (NYSE:GSK)
$ 34.08 -0.04 (-0.12%) Market Cap: 69.61 Bil Enterprise Value: 84.95 Bil PE Ratio: 21.96 PB Ratio: 3.90 GF Score: 71/100

Q4 2020 GlaxoSmithKline PLC Earnings Call Transcript

Feb 03, 2021 / 02:00PM GMT
Release Date Price: $36.42 (-5.77%)
Operator

Good afternoon, ladies and gentlemen. And welcome to the Analyst Call on the GSK Fourth Quarter 2020 Results. I will now hand you over to Iain Mackay, Chief Financial Officer, who will introduce today's session.

Iain James Mackay
GlaxoSmithKline plc - CFO & Executive Director

Good morning and good afternoon. Thank you for joining us for our Full Year 2020 Results, which were issued earlier today. Normally, Sarah Elton-Farr, our Director of IR, would lead this call, but unfortunately, Sarah has been out ill for a couple of weeks, and this is literally her first day back, so she's on listening-mode only today.

You should have received our press release and can view presentation on the GSK website. For those not able to view, the webcast slides that accompany today's call are located on the Investors section of the GSK website.

Before we begin, please refer to Slide 2 of our presentation for our cautionary statements. Our speakers today are Emma Walmsley; myself, Iain Mackay; Luke Miels; David Redfern; Brian McNamara; and Dr. Hal Barron

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot